| 000 | 01369 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513124729.0 | ||
| 264 | 0 | _c19970918 | |
| 008 | 199709s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/s0002-9149(97)00573-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTcheng, J E | |
| 245 | 0 | 0 |
_aImpact of eptifibatide on early ischemic events in acute ischemic coronary syndromes: a review of the IMPACT II trial. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cAug 1997 |
||
| 300 |
_a21B-28B p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEptifibatide |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xmortality |
| 650 | 0 | 4 |
_aPeptides _xtherapeutic use |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 80 _gno. 4A _gp. 21B-28B |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9149(97)00573-0 _zAvailable from publisher's website |
| 999 |
_c9269922 _d9269922 |
||